. Author manuscript; available in PMC: 2015 Jun 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2014 Feb 16;20(6):787–793. doi: 10.1016/j.bbmt.2014.02.010

Table 1. Demographics of 125 patients and their grafts.

Characteristic	Value

Median age	42 years (range 0.9-69)

Median weight	67 kilogram (range 8-125)

Diagnosis, N (%)
AML	43 (34%)
ALL	24 (19%)
Other leukemia, MDS, CML	12 (10%)
Lymphoma, CLL	46 (37%)

Conditioning, N (%)
Myeloablative	94 (75%)
Non-myeloablative	31 (25%)

Median unit-recipient HLA-match
10 allele	6/10 (range 2-9/10)

Median Infused TNC Dose × 10⁷/kg
Larger unit	2.7 (range 1.4-11.3)
Smaller unit	2.0 (range 0.9-7.1)

N indicates number; AML, acute myelogenous leukemia; ALL, acute lymphoblastic leukemia; MDS, myelodysplastic syndrome; CML, chronic myelogenous leukemia; CLL, chronic lymphocytic leukemia; HLA, human leukocyte antigen; TNC: total nucleated cell dose.